What is BeatO App?
BeatO App is an innovative digital health company founded in 2015 and headquartered in New Delhi, India. It specializes in diabetes management, offering a comprehensive suite of services and products accessible via smartphone. The company's core offerings include smartphone-integrated glucometers designed for convenience and accuracy, alongside features that allow users to track progress towards their health goals, such as blood glucose levels, steps, and calorie intake. BeatO App aims to provide a holistic solution for individuals seeking to manage their diabetes effectively through user-friendly technology and data-driven insights.
How much funding has BeatO App raised?
BeatO App has raised a total of $38.6M across 2 funding rounds:
Other Financing Round
$5.6M
Series B
$33M
Other Financing Round (2021): $5.6M with participation from W Health Ventures, Leo Capital, Pharmeasy, Merisis VP, and Orios Venture Partners
Series B (2022): $33M led by HealthQuad, Lightrock India, and Flipkart
Key Investors in BeatO App
HealthQuad
HealthQuad is India's leading healthcare innovation fund focused on nurturing innovative models that transform healthcare and create an inclusive impact on communities. The company invests across the healthcare value chain, emphasizing disease prevention, quality of care, and leveraging technology to improve business models.
Flipkart
Founded in 2007, Flipkart is headquartered in Karnataka, India. They are an e-commerce marketplace with products across many categories including home & kitchen, games, clothing, furniture, and more.
Leo Capital
Leo Capital is a venture capital fund, investing in early stage, technology centric opportunities, primarily in India. The company invest anywhere from $300K - $1.5M in early seed rounds or pre-Series A rounds.
What's next for BeatO App?
With the recent infusion of $33M in a Series B round, BeatO App is poised for accelerated expansion and further development of its digital health ecosystem. The strategic backing from investors like HealthQuad, Lightrock India, and Flipkart suggests a focus on scaling operations, enhancing technological capabilities, and potentially broadening its market reach within India and beyond. This capital injection will likely fuel advancements in product innovation, user engagement strategies, and partnerships to solidify BeatO App's position as a leader in the digital diabetes care market, addressing a critical need in public health.
See full BeatO App company page
